Sprix approved for acute moderate to moderately severe pain - MPR
Links shared publicly online about this topic.
- 1,162total visits
Sprix approved for acute moderate to moderately severe pain - MPR
empr.com —
View full resource at empr.com
Tags: Pain, Nose, Pharma, FDA, NSAIDs, Toradol
Most Recently Shared on May 17, 2010 at 4:55 pm By:
MPR News: Sprix approved for acute moderate to moderately severe pain: The FDA has approved Sprix (ketorolac trome... http://bit.ly/beALNP
Nucynta ER Approved For Moderate To Severe Chronic Pain Control - QualityPoint Technologies
qualitypointtech.net — “An oral painkiller called Nucynta ER (tapentadol extended-release tablets), has been approved by the U.S. Food and Drug Administration (FDA), Janssen Pharmaceuticals, Inc. announced. The medication is designed to be taken twice daily for the control of moderate to severe chronic pain in adults when a continuous, 24-hour opioid analgesic is needed for an extended period. The immediate-release version of Nucynta was FDA approved in 2008 for the treatment of acute pain in adults aged at least 18 ye” View full resource at qualitypointtech.net
Most Recently Shared on August 28, 2011 at 3:00 am By:
Nucynta ER Approved For Moderate To Severe Chronic Pain Control: An oral painkiller called Nucynta ER (tapentadol ... http://t.co/70df3Up
Nucynta ER Approved For Moderate To Severe Chronic Pain Control - QualityPoint Technologies
qualitypointtech.net — “An oral painkiller called Nucynta ER (tapentadol extended-release tablets), has been approved by the U.S. Food and Drug Administration (FDA), Janssen Pharmaceuticals, Inc. announced. The medication is designed to be taken twice daily for the control of moderate to severe chronic pain in adults when a continuous, 24-hour opioid analgesic is needed for an extended period. The immediate-release version of Nucynta was FDA approved in 2008 for the treatment of acute pain in adults aged at least 18 ye” View full resource at qualitypointtech.net
Most Recently Shared on August 28, 2011 at 1:45 am By:
Nucynta ER Approved For Moderate To Severe Chronic Pain Control: An oral painkiller called Nucynta ER (tapentadol ... http://t.co/kI0UXln
Nucynta ER (Tapentadol Extended-Release Tablets) Receives FDA Approval for the Management of Moderate to Severe Chronic Pain
drugs.com — “Nucynta ER (tapentadol) is used to treat moderate to severe acute pain. Includes Nucynta ER side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on August 26, 2011 at 10:17 pm By:
FDA Approves Nucynta ER for the Management of Moderate to Severe Chronic Pain - http://t.co/QwYR6Me
QRxPharma seeks NDA approval for MoxDuo IR
news-medical.net — “QRxPharma Limited announced today initiation of the New Drug Application (NDA) approval process for MoxDuo IR with the United States Food and Drug Administration (FDA). This NDA submission sets the stage for the regulatory approval process for MoxDuo IR for the treatment of moderate to severe acute pain, a $2.5 billion segment of the $8 billion spent annually on prescription opioids in the US.” View full resource at news-medical.net
Most Recently Shared on July 18, 2011 at 10:25 am By:
QRxPharma seeks NDA approval for MoxDuo IR: QRxPharma Limited announced today initiation of the New Drug Applica... http://bit.ly/omZjOc
FDA Approves an Abuse-Resistant Painkiller, Oxecta – TIME Healthland
healthland.time.com — “Pfizer Inc. and Acura Pharmaceuticals Inc. said Monday the Food and Drug Administration (FDA) approved a powerful painkiller that is designed to be harder to abuse. The FDA cleared marketing of Oxecta as an immediate-release treatment for acute or moderate-to-severe pain.” View full resource at healthland.time.com
Most Recently Shared on June 21, 2011 at 1:49 am By:
HealthIT Policy Health IT and Health News
RT @TimeHealthland: FDA Approves an Abuse-Resistant Painkiller, Oxecta http://ti.me/jmHBs5
Oxecta Approved for Acute and Chronic Moderate to Severe Pain - ONA
oncologynurseadvisor.com — “Pfizer and Acura Pharmaceuticals announced that the FDA has approved Oxecta (oxycodone HCl tablets) for the management of acute and chronic moderate to severe pain where the use of an opioid analgesic is appropriate.” View full resource at oncologynurseadvisor.com
Most Recently Shared on June 20, 2011 at 5:22 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Oxecta Approved for Acute and Chronic Moderate to Severe Pain http://goo.gl/fb/z6lZO
Sprix Nasal Spray Available for Acute Pain - ONA
oncologynurseadvisor.com — “Regency Therapeutics and Daiichi Sankyo have made available Sprix (ketorolac tromethamine) Nasal Spray for the short term (up to 5 days) management of moderate to moderately severe pain that requires analgesia at the opioid level.” View full resource at oncologynurseadvisor.com
Most Recently Shared on May 17, 2011 at 7:15 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Sprix Nasal Spray Available for Acute Pain http://goo.gl/fb/DGtKr
Medical News: FDA Approves Intranasal NSAID - in Product Alert, Devices and Vaccines from MedPage Today
medpagetoday.com — “WASHINGTON -- The FDA approved ketorolac tromethamine (Sprix), a short-term use, intranasal painkiller for moderate to moderately severe pain, for use in patients who require an analgesic at the opioi” View full resource at medpagetoday.com
Most Recently Shared on May 19, 2010 at 9:15 pm By:
Patricia Grace Eldercare Expert
FDA Approves Intranasal NSAID: WASHINGTON (MedPage Today) -- The FDA approved ketorolac tromethamine (Sprix), a sh... http://bit.ly/dz5cbH
Sprix Approved for Moderate-to-Severe Pain --Doctors Lounge
doctorslounge.com — “Sprix Approved for Moderate-to-Severe Pain --Doctors Lounge” View full resource at doctorslounge.com
Most Recently Shared on May 18, 2010 at 9:18 pm By:
Drugs and Devices OW OW Health
Sprix Approved for Moderate-to-Severe Pain: A non-narcotic nasal spray http://bit.ly/cTFanL
NursingCenter
nursingcenter.com — “. NursingCenter.com... Over 900 CE activities and thousands of clinical articles from over 50 leading Lippincott Williams & Wilkins nursing journals, including: The American Journal of Nursing, Nursing2007, Nursing Management, The Nurse Practitioner, Nursing Made Incredibly Easy, and many more specialty journals.” View full resource at nursingcenter.com
Most Recently Shared on May 18, 2010 at 11:55 am By:
Lisa Morris Bonsall Nurse and Advanced Practice Nurse
Sprix Approved for Moderate-to-Severe Pain http://bit.ly/bkKFyQ Interesting...it's a nonnarcotic nasal spray (contains ketorolac)
Sprix Approved for Moderate-to-Severe Pain (HealthDay)
links.assetize.com — “Assetize allows publishers to brand and monetize shared links.” View full resource at links.assetize.com
Most Recently Shared on May 18, 2010 at 7:43 am By:
Sprix Approved for Moderate-to-Severe Pain (HealthDay) http://bit.ly/cJAIg6
ROXRO Announces FDA Approval of SPRIX - FiercePharma
fiercepharma.com — “ROXRO Announces FDA Approval of SPRIX (Ketorolac Tromethamine) - First Non-narcotic Intranasal Analgesic for Moderate to Moderately Severe Pain - Download image MENLO PARK, Calif., May 17... Read more...” View full resource at fiercepharma.com
Most Recently Shared on May 17, 2010 at 6:38 pm By:
ROXRO Announces FDA Approval of SPRIX. http://bit.ly/ae7OkB
FDA approves ROXRO PHARMA's SPRIX Nasal Spray
news-medical.net — “ROXRO PHARMA, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved SPRIX" (ketorolac tromethamine) Nasal Spray, for the short-term (up to 5 days) management of acute moderate to moderately severe pain that requires analgesia at the opioid level.” View full resource at news-medical.net
Most Recently Shared on May 17, 2010 at 5:47 pm By:
Stroke News: FDA approves ROXRO PHARMA's SPRIX Nasal Spray: ROXRO PHARMA, Inc. announced today that the U.S. Foo... http://twurl.nl/jp5kc1
FDA Approves New Morphine Concentrations for Pain Relief
spine-health.com — “The U.S. Food and Drug Administration (FDA) has approved specific concentrations of Morphine Sulfate Oral Solution " 100 milligrams per 5mL or 20 milligrams per 1 ml " for treating opioid-tolerant patients with moderate to severe acute or chronic pain.” View full resource at spine-health.com
Most Recently Shared on January 27, 2010 at 6:17 pm By:
FDA Approves New Morphine Concentrations for Acute and Chronic Pain Relief http://bit.ly/cnt6wY
FDA Approves Morphine Sulfate Oral Solution For Relief Of Acute And Chronic Pain
medicalnewstoday.com — “The u.s. food and drug administration approved morphine sulfate oral solution for the relief of moderate to severe, acute and chronic pain in opioid-tolerant patients. this medicine will be availa” View full resource at medicalnewstoday.com
Most Recently Shared on January 27, 2010 at 3:10 pm By:
MNT Pain News Health News and Pain Management
FDA Approves Morphine Sulfate Oral Solution For Relief Of Acute And Chronic Pain http://mnt.to/3wPr #pain
Advertisement
